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Polychlorinated biphenyls (PCBs) are con-
sidered important environmental contami-
nants (1). Even though the production of
PCBs was banned in 1976 in the United
States, there is still great concern about the
potential toxic effects of PCBs that have
been released into the environment. Recent
investigations showed that human popula-
tions with a high fish consumption have
considerably higher concentrations of PCBs
and PCB metabolites in their tissues than
control populations (2–4).
The lipophilic character of PCBs enables
these compounds to bioaccumulate in adi-
pose tissues. Depending on the chlorine sub-
stitution pattern, PCBs are more or less
easily oxygenated by cytochromes P450, of
which CYP1A and CYP2B are considered
the most important isozymes to catalyze this
reaction (5). Oxygenation of PCBs may
occur by direct insertion, giving a hydroxy-
lated metabolite (OH-PCB), or by epoxide
formation. The epoxide may rearrange to
give an OH-PCB or react with glutathione
to yield a mercapturic acid or a methyl sul-
fone conjugate. Methyl sulfone-PCBs can
covalently bind to proteins, cause induction
of cytochrome P450 enzymes, or exert
endocrine-related effects (5). 
Most metabolized PCBs are excreted
through urine and bile (6). Some OH-PCBs
accumulate in blood plasma. These metabo-
lites have a chlorine substitution pattern that
resembles the iodine substitution on thyrox-
ine, a thyroid hormone, which enables them
to bind to the thyroxine transport protein.
This apparently causes reduced blood plasma
thyroid levels, which has been linked to
impaired fetal development in pregnant
individuals (7). PCBs and methylsulfone
PCBs also induce uridine diphosphate-glu-
curonosyltransferase (UGT), including the
form that glucuronidates thyroxine (8).
Schuur et al. (9,10) described several
OH-PCBs that inhibit thyroxine sulfation,
the major regulatory pathway for this thy-
roid hormone. More recently, several
OH-PCBs were found to be very potent
inhibitors of estrogen sulfotransferase (EST),
which may explain the estrogenic effect of
PCBs (11). 
PCBs are often found together with
polynuclear aromatic hydrocarbons (PAHs)
in contaminated aquatic environments.
Aquatic organisms, and especially bottom
dwellers like channel catﬁsh (Ictalurus punc-
tatus), are prone to exposure to these com-
pounds, either through their diet or through
uptake over the gills (12). Intestinal absorp-
tion is an important route for uptake and
first-pass metabolism of lipophilic environ-
mental toxicants in ﬁsh (13). 
One of the most widely studied PAHs is
benzo[a]pyrene (BaP), which after oxygena-
tion by cytochromes P450 can form toxic
and carcinogenic metabolites. In previous
work we demonstrated that intestinal
mucosa of catfish has inducible CYP1A
activity and that phenolic metabolites of BaP
are easily conjugated by phenol-type sulfo-
transferases (SULT) and UGT (14–16).
These phase II conjugation reactions are
important detoxification pathways for phe-
nolic metabolites of PAHs, which may oth-
erwise be further oxidized to more toxic
quinones and diol-epoxides (17–19).
Doi et al. (20) demonstrated that a
model coplanar PCB [3,3´,4,4´-tetrachloro-
biphenyl (TCB)] was slowly metabolized to
OH-PCB in catfish intestine (20). This
raised the question of the inhibitory effect of
OH-PCBs on the conjugation of hydroxy-
lated BaP. In this study we investigated the
effect of a set of OH-PCBs on the sulfation
and glucuronidation of 3-OH-BaP in sub-
cellular fractions of channel catﬁsh intestinal
mucosa. The OH-PCBs selected for this
study were potential metabolites of the toxic
coplanar congener 3,3´,4,4´-TCB and of
selected ortho-chlorinated tetra, penta, and
hexachlorobiphenyls found to persist in the
environment (21). We compared inhibition
characteristics of the OH-PCBs for both
enzymes and investigated inhibition kinetics.
Materials and Methods
Chemicals. 4-Hydroxy-2´,3,5,5´-TCB (4´-
OH-CB 72) and 4-hydroxy-2´,3,3´,5,5´,6´-
hexachlorobiphenyl (4´-OH-CB 165) were
purchased from AccuStandard, Inc. (New
Haven, CT). The other OH-PCBs were
Address correspondence to P. van den Hurk,
Department of Medicinal Chemistry, College of
Pharmacy, University of Florida, PO Box 100485,
1600 SW Archer Road, Gainesville, FL 32610
USA. Telephone: (352) 856-1971. Fax: (352)
846-1972. 
*Current address: Department of Environmental
Toxicology, Clemson University, PO Box 709,
Pendleton, SC 29670 USA. Telephone: (864) 646-
2186. Fax: (864) 646-2277. E-mail: pvdhurk@
clemson.edu
We thank L. Rowland-Faux for help with prepar-
ing cytosol and microsomes. 
This study was supported by grants ES 05781,
ES 07375, and ES 07380 from the National
Institute of Environmental Health Sciences. 
Received 20 June 2001; accepted 16 October
2001.
Articles
Polychlorinated biphenyls (PCBs) can be metabolized by cytochromes P450 to hydroxylated bio-
transformation products. In mammalian studies, some of the hydroxylated products have been
shown to be strong inhibitors of steroid sulfotransferases. As a part of ongoing research into the
bioavailability of environmental pollutants in catfish intestine, we investigated the effects of a
series of hydroxylated PCBs (OH-PCBs) on two conjugating enzymes, phenol-type sulfotrans-
ferase and glucuronosyltransferase. We incubated cytosolic and microsomal samples prepared
from intestinal mucosa with 3-hydroxy-benzo[a]pyrene and appropriate cosubstrates and mea-
sured the effect of OH-PCBs on the formation of BaP-3-glucuronide and BaP-3-sulfate. We used
PCBs with 4, 5, and 6 chlorine substitutions and the phenolic group in the ortho, meta, and para
positions. OH-PCBs with the phenolic group in the ortho position were weak inhibitors of sulfo-
transferase; the median inhibitory concentration (IC50) ranged from 330 to 526 µM. When the
phenol group was in the meta or para position, the IC50 was much lower (17.8–44.3 µM). The
OH-PCBs were more potent inhibitors of glucuronosyltransferase, with IC50s ranging from 1.2
to 36.4 µM. The position of the phenolic group was not related to the inhibitory potency: the
two weakest inhibitors of sulfotransferase, with the phenolic group in the ortho position, were
100 times more potent as inhibitors of glucuronosyltransferase. Inhibition of glucuronosyltrans-
ferase by low concentrations of OH-PCBs has not been reported before and may have important
consequences for the bioavailability, bioaccumulation, and toxicity of other phenolic environmen-
tal contaminants. Key words: biotransformation, enzyme inhibition, polychlorinated biphenyls,
sulfotransferase, UDP-glucuronosyltransferase, xenobiotics. Environ Health Perspect
110:343–348 (2002). [Online 1 March 2002]
http://ehpnet1.niehs.nih.gov/docs/2002/110p343-348vandenhurk/abstract.htmlsynthesized as described below. 3´-Phospho-
adenosine-5´-phosphosulfate (PAPS) was
obtained from S.S. Singer (University of
Dayton, Dayton, OH), and uridine 5´-
diphosphoglucuronic acid (UDPGA) was
obtained from Sigma (St. Louis, MO).
3-Hydroxy-BaP, BaP-3-sulfate, and BaP-3-β-
D-glucopyranosuronic acid were purchased
from Midwest Research Institute (Kansas
City, MO) through the Chemical Carcinogen
Reference Standard Repository of the
National Cancer Institute. Other reagents
were the highest grade available from Fisher
Scientiﬁc (Atlanta, GA) and Sigma. 
Synthesis and structural verification of
OH-PCBs. PCBs and PCB metabolites were
anticipated to be human carcinogens and
were therefore handled in an appropriate
manner. 2-Hydroxy-3,3´,4,4´-TCB (2-OH-
CB 77), 5-hydroxy-3,3´,4,4´-TCB (5-OH-
CB 77), and 4-hydroxy-2,3,3´,4´-TCB
(4-OH-CB 56) were synthesized by the
Cadogan coupling (22,23) of 3,4-dichloro-
aniline with 2,3-dichloroanisole and subse-
quent demethylation of the methoxy PCBs
with boron tribromide. The structures of
2-OH-CB 77 and 4-OH-CB 56 were
assigned by 1H nuclear Overhauser effect
(NOE) nuclear magnetic resonance (NMR)
experiments. 4´-Hydroxy-3,3´,4,5-TCB
(4´-OH-CB 78) was synthesized by coupling
of 4-amino-2,6-dichlorophenol and
1,2-dichlorobenzene. The reaction mixture
was methylated with dimethyl sulfate.
4-Methoxy-3,3´,4´,5-TCB was isolated by
flash column chromatography on silica gel
with petroleum ether:dichloromethane
[8.5:1.5 (v/v)] and petroleum ether:iso-
propylether (9.75:0.25 v/v). The OH-PCB
was obtained by demethylation with boron
tribromide. 6-Hydroxy-3,3´,4,4´-TCB
(6-OH-CB 77) was synthesized from
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6-OH-CB 77 4´-OH-CB 72
4´-OH-CB 78
4´-OH-CB 165
Table 1. Analytical data for methoxy PCBs.
PCB mp 1H-NMR MS (m/z) (relative intensity, %)
2-Methoxy-3,3´,4,4´-TCB 79°C (CD2Cl2, 200 MHz) δ 3.53 (s, -OCH3, 3H), 7.21 (d, J = 8.4 Hz, H6),  320 (78, C13H8Cl4O·+), 305 (36, M-CH3), 
7.34 (d, J = 8.4 Hz, H5), 7.43 (d, J = 2.1 Hz, d, J = 8.4, H6´),  277 (29, M-CO-CH3), 207 (26, M-CO-CH3-Cl2)
7.54 (d, J = 8.4 Hz, H5´), 7.68 (d, J = 2.1 Hz, H2´)
5-Methoxy-3,3´,4,4´-TCB 146°C (CD2Cl2, 200 MHz) δ 3.97 (s, -OCH3, 3H), 7.01 (d, J = 2.0 Hz, H6),  320 (77, C13H8Cl4O·+), 277 (29, M-CO-CH3), 
7.29 (d, J = 2.0 Hz, H2), 7.43 (d, J = 2.2 Hz, d, J = 8.4, H6´),  207 (22, M-CO-CH3-Cl2)
7.56 (d, J = 8.4 Hz, H5´), 7.69 (d, J = 2.2 Hz, H2´)
4-Methoxy-2,3,3´,4´-TCB 168°C (CD2Cl2, 200 MHz) δ 3.94 (s, -OCH3, 3H), 6.96 (d, J = 8.7 Hz, H5),  320 (64, C13H8Cl4O·+), 270 (100, M-Cl-CH3), 
7.22 (d, J = 8.7 Hz, H6), 7.27 (d, J = 2.0 Hz, d, J = 8.4, H6´), 207 (25, M-CO-CH3-Cl2)
7.50 (d, J = 2.0 Hz, H2´), 7.52 (d, J = 8.4 Hz, H5´)
4-Methoxy-3,3´,4´,5-TCB 122–123°C (CD2Cl2, 200 MHz) δ 3.92 (s, -OCH3, 3H), 7.39 (d, J = 2.2 Hz, d, J = 8.4, H6´),  320 (76, C13H8Cl4O·+), 305 (61, M-CH3), 
7.52 (s, H2 and H6), 7.54 (d, J = 8.4 Hz, H5´), 7.65 (d, J = 2.2 Hz, H2´)  277 (24, M-CO-CH3), 207 (26, M-CO-CH3-Cl2) 
6-Methoxy-3,3´,4,4´-TCB 139°C (CD2Cl2, 200 MHz) δ 3.79 (s, -OCH3, 3H), 7.08 (s, H2),  320 (76, C13H8Cl4O·+), 270 (36, M-Cl-CH3), 
7.32 (d, J = 2.0 Hz, d, J = 8.4, H6´),7.35 (s, H5), 7.48 (d, J = 8.4 Hz, H5´),  207 (20, M-CO-CH3-Cl2)
7.58 (d, J = 2.0 Hz, H2´)
Abbreviations: δ, chemical shift (ppm); d, doublet; J, coupling constant; s, singlet.
Table 2. Analytical data for OH-PCBs. 
PCB mp 1H-NMR MS (m/z) (relative intensity, %)
2-OH-CB 77 177°C (CD2Cl2, 200 MHz) δ 5.99 (s, -OH, 1H), 7.13 (d, J = 8.4 Hz, H6),  306 (53, C12H6Cl4O·+), 207 (100, M-99)
7.18 (d, J = 8.4 Hz, H5), 7.39 (d, J = 2.1 Hz, d, J = 8.4, H6´), 
7.52 (d, J = 8.4 Hz, H5´), 7.65 (d, J = 2.1 Hz, H2´)
5-OH-CB 77 169°C (CD2Cl2, 200 MHz) δ 5.86 (s, -OH, 1H), 7.12 (d, J = 2.0 Hz, H6),  306 (80, C12H6Cl4O·+), 207 (16, M-99)
7.25 (d, J = 2.0 Hz, H2), 7.38 (d, J = 2.2 Hz, d, J = 8.4, H6´), 
7.52 (d, J = 8.4 Hz, H5´), 7.64 (d, J = 2.2 Hz, H2´)
4-OH-CB 56 163°C (CDCl3, 400 MHz) δ 5.85 (s, -OH, 1H), 7.01 (d, J = 8.6 Hz, H6),  306 (74, C12H6Cl4O·+), 207 (29, M-99)
7.15 (d, J = 8.6 Hz, H5), 7.24 (d, J = 2.0 Hz, d, J = 8.4, H6´), 
7.50 (d, J = 2.0 Hz, H2´), 7.50 (d, J = 8.4 Hz, H5´) 
4´-OH-CB 78 191°C (CDCl3, 400 MHz) δ 5.94 (s, -OH, 1H), 7.33 (d, J = 2.0 Hz, d, J = 8.4, H6´),  306 (74, C12H6Cl4O·+), 207 (61, M-99)
7.45 (s, H2 and H6), 7.50 (d, J = 8.4 Hz, H5´), 7.58 (d, J = 2.2 Hz, H2´)
6-OH-CB 77 135°C (CDCl3, 400 MHz) δ 5.23 (s, -OH, 1H), 7.08 (s, H2),  306 (74, C12H6Cl4O·+), 236 (54, M-Cl2)
7.31 (d, J = 2.0 Hz, d, J = 8.4, H6´), 7.31 (s, H5), 7.55 (d, J = 8.4 Hz, H5´), 
7.57 (d, J = 2.0 Hz, H2´)
Abbreviations: δ, chemical shift (ppm); d, doublet; J, coupling constant; s, singlet.3,4-dichloroaniline and 3,4-dichlorophenol
in an analogous manner. The structures of
the OH-PCBs used in this study are shown
in Figure 1. 
We characterized all OH-PCBs by 1H
NMR and mass spectrometry (MS) and we
observed their melting points (mp). The 1H
NMR spectra were recorded on a Varian
Gemini 200 or a Varian INOVA 400 (Varian
Inc., Walnut Creek, CA) by using CD2Cl2 or
CDCl3 (Cambridge Isotope Laboratories,
Inc., Andover, MA) as a solvent and tetram-
ethylsilane as an internal standard. 1H NOE
NMR experiments were performed on a
Bruker AM-400 (Bruker NMR, Billerica,
MA). Gas chromatography (GC)–MS analy-
ses were performed in the mass spectrometry
facility of the University of Kentucky
(Lexington, KY). The purity of all com-
pounds was analyzed with a Hewlett Packard
5890 A gas chromatograph equipped with an
HP-1 (methyl silicone gum) column (Hewlett
Packard, Avondale, PA). The following con-
ditions were used for the GC analysis: injec-
tor: 200°C; ﬂame ionization detector: 320°C;
starting temperature: 130°C; ﬁnal tempera-
ture: 310°C; heating rate: 8°/min. The purity
was > 99% based on relative peak area. The
analytical data for methoxy PCBs are shown
in Table 1 and those for the OH-PCBs are
shown in Table 2. 
Animals. We used cytosol and micro-
somes of four channel catﬁsh (Ictaluris puncta-
tus) in this study (two females and two males)
with weights ranging from 1,664 to 2,016 g.
All ﬁsh were kept in ﬂowing well water and
fed regular ﬁsh chow diet (Silvercup, Murray,
UT). Care and treatment of the animals was
conducted according to the guidelines of the
University of Florida Institutional Animal
Care and Use Committee. Cytosol and
microsomes from intestinal mucosa were pre-
pared as described previously (24).
Sulfation assay. The reaction mixture for
measuring the sulfation of 3-OH-BaP con-
sisted of 0.4% bovine serum albumin (BSA),
50 mM Tris (pH 7.0), 20 µM PAPS, 25 µg
cytosolic protein, 1 µM 3-OH-BaP, and
varying concentrations of inhibitor in a total
reaction volume of 500 µL. All inhibitors
used in this study were dissolved in dimethyl-
sulfoxide (DMSO). DMSO concentration in
the ﬁnal reaction mix was kept below 0.5%
and did not affect the enzymatic reaction or
the ﬂuorescence of the sulfation product. The
substrate (3-OH-BaP in methanol) was
blown dry in the final reaction tube. PAPS
was added to this tube. The enzyme, in
buffer with BSA, was preincubated with the
inhibitor for 5 min at 35°C. The entire mix
was then transferred to the tube with sub-
strate and PAPS and incubated for 10 min.
Reaction was stopped with 2 mL ice-cold
methanol. Precipitated protein was pelleted
by centrifugation; 2 mL of the clear solution
was then mixed with 0.5 mL sodium hydrox-
ide (1 N) and ﬂuorescence of BaP-3-SO4 was
measured at the optimal excitation/emission
wavelengths of 294/415 nm (14).
Glucuronidation assay. The reaction
mixture for measuring the glucuronidation
of 3-OH-BaP consisted of 0.1 M Tris-HCl
buffer (pH 7.6), 5 mM MgCl2, 200 µM
UDPGA, 50 µg microsomal protein, 1 µg
3-OH-BaP, and Lubrol PX (0.5 mg/mg pro-
tein; Sigma). The assay procedure was iden-
tical to the sulfation assay described above,
except the ﬁnal incubation time was 30 min
and the fluorescence of BaP-3-glucuronic
acid was measured at excitation/emission
wavelengths of 300/421 nm (25). 
To investigate the inhibition kinetics, we
changed the reaction conditions by lowering
the substrate concentration to < 50 nM and
using a protein concentration of 10 µg/mL
reaction mix and a 2-min incubation time to
avoid substrate inhibition and to keep the
reaction in the linear range.
Data analysis. Inhibition data are pre-
sented as percentage of inhibition compared
with the controls without inhibitor. Each
inhibitor was used with cytosol and micro-
somes of three different individuals. Each
inhibitor concentration was tested in dupli-
cate. Fifty percent inhibition concentrations
(IC50) were obtained from regression analysis
through the linear part of the inhibition
curves and are presented as mean ± SD from a
pool of three individual ﬁsh. Signiﬁcant dif-
ferences between IC50 values were obtained
by one-way analysis of variance, followed by
Tukey’s test. Inhibition kinetics were
retrieved from double reciprocal (Lineweaver-
Burke) and Eadie-Hofstee plots.
Results
Inhibition of sulfation. We calculated inhibi-
tion of the sulfation of 3-OH-BaP by six dif-
ferent PCB metabolites as the percentage of
control SULT activity without inhibitor.
Control activity (mean ± SD) was 0.98 ± 0.21
nmol/min/mg cytosolic protein. Inhibition
curves for the PCB metabolites show two
clearly separated groups with different inhibi-
tion potential (Figure 2). The more potent
inhibitors reduced the sulfation of 3-OH-BaP
to around 10% of the control activity at 100
µM inhibitor. The less potent inhibitors were
tested up to concentrations of 500 and 1,000
µM, but solubility of the PCB metabolites
became a limiting factor at these high concen-
trations. The IC50 values for the two poor
inhibitors (330 µM for 6-OH-CB 77 and
526 µM for 2-OH-CB 77) were signiﬁcantly
different from each other and from the four
more potent inhibitors (Figure 3; p < 0.001
for all comparisons). There were no signiﬁ-
cant differences in IC50 values among the four
potent inhibitors, which ranged from 17.8 to
44.3 µM (p > 0.05 for all comparisons).
From these data it appears that the posi-
tion of the hydroxyl group is of crucial
importance for the inhibitory potency of the
OH-PCBs tested in this study. When the
hydroxyl group was in the 2 or 6 position
(ortho), the PCB metabolite was far less
potent than when the hydroxyl group was in
the 4 or 5 position (meta and para). There
was no apparent difference between the 4 and
5 position (4´-OH-CB 78 and 5-OH-CB 77)
or between the number of chlorine substitu-
tions on the opposite ring when the hydroxyl
group was in the 4 position (4´-OH-CB 78
and 4´-OH-CB 165). Even though the 
planar metabolites (5-OH-CB 77 and
4´-OH-CB 78) seemed to be slightly more
potent inhibitors than the nonplanar com-
pounds (Figure 3), these differences were not
statistically signiﬁcant (p > 0.05).
Kinetics of sulfation inhibition. To deter-
mine the type of inhibition, we incubated a
concentration series of 3-OH-BaP with
increasing amounts of one of the OH-PCBs
with the hydroxyl group in the ortho posi-
tion, sided by two chlorine substitutions
(4´-OH-CB 72). The OH-PCBs with this
conﬁguration appeared to be the most potent
inhibitors. The IC50 for this congener was
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Figure 2. Inhibition of 3-OH-BaP sulfation by dif-
ferent OH-PCBs in channel catfish intestinal
cytosol, presented as the percentage reduction of
the control rate. Error bars represent SD.
Figure 3. IC50 values for the inhibition of 3-OH-BaP
sulfation by different OH-PCBs in channel catﬁsh









































































































546.6 ± 2.2 µM (mean ± SD) and was very
consistent among the seven different sub-
strate concentrations (Figure 4). However, a
double reciprocal (Lineweaver-Burke) plot of
these data resulted in nonlinear regresssion
lines, which was confirmed by plotting the
data in an Eadie-Hofstee plot. The observed
nonlinear inhibition kinetics obscure the
actual type of inhibition.
Inhibition of glucuronidation. We cal-
culated inhibition of the glucuronidation
of 3-OH-BaP by PCB metabolites as the
percentage of control UGT activity with-
out inhibitor, as described above for sulfa-
tion. Control activity was 0.16 ± 0.04
nmol/min/mg microsomal protein (mean ±
SD). The inhibition curves show that the
PCB metabolites were much more potent
inhibitors of glucuronidation than of sulfa-
tion (Figure 5). The IC50s ranged from 1.17
to 36.4 µM (Figure 6). The differences were
most pronounced for 6-OH-CB 77 and
2-OH-CB 77, the metabolites with the
hydroxyl group in the ortho position. These
metabolites were almost two orders of magni-
tude more potent as inhibitors of glu-
curonidation than of sulfation (4.3 and 6.9
µM vs. 330 and 526 µM). On the other
hand, the hexachlorobiphenyl metabolite had
an almost identical IC50 for both enzymes.
Structural differences between the PCB
metabolites investigated here seem to be less
predictable for inhibition of glucuronidation
than they are for inhibition of sulfation. The
importance of a hydroxyl group in the meta
or para position does not hold for inhibition
of UGT as it does for SULT. However, for
UGT the highest chlorine-saturated metabo-
lite was the least potent inhibitor (36.4 µM
for 4´-OH-CB 165, signiﬁcantly higher than
all other metabolites, p < 0.001), whereas for
SULT there appeared to be no relationship
between chlorine substitution and inhibition. 
Kinetics of glucuronidation inhibition.
The kinetics of the inhibition of 3-OH-BaP
glucuronidation by 4´-OH-CB 72 were
measured at lower substrate and protein con-
centrations to avoid substrate inhibition.
Under these conditions the IC50 for this
inhibitor was around 1 µM, with almost
complete inhibition at 5 µM (Figure 7).
These observations are consistent with the
data from previous experiments obtained at
much higher substrate concentrations
(Figure 5). However, Lineweaver-Burke and
Eadie-Hofstee plots revealed that the ana-
lytic variation in the data from the treat-
ments with higher inhibitor concentrations
was too high to draw reliable conclusions
about the type of inhibition.
Discussion
Recently, inhibition of phase II enzymes by
OH-PCBs has received considerable attention
(26). Kester et al. (11) found a number of
OH-PCBs to be extremely potent inhibitors
of recombinant human EST. IC50 values for
the most potent compounds were found in
the subnanomolar range (0.10–0.20 nM).
Strong inhibition of EST by OH-PCBs
would result in a reduced removal of estro-
gen, which may lead to higher estrogen con-
centrations in target tissues. This may
explain the estrogenic effect of OH-PCBs, as
reported elsewhere (27).
Four of the OH-PCBs investigated here
were also tested as inhibitors of EST (11),
and though the IC50s are about ﬁve orders of
magnitude lower for EST than for phenol-
type SULT, the ranking of the inhibitors is
the same, with 4´-OH-CB 78 being the
most potent, 4´-OH-CB 165 intermediate,
and 2-OH-CB 77 and 6-OH-CB 77 the
least potent. 
Studies of PCB concentrations in people
have shown that metabolites as well as parent
PCB are present. Inuit men had mean whole-
blood concentrations of 12.9 ng/g wet weight
for total PCBs and 1.7 ng/g wet weight for
OH-PCBs, corresponding to molar concen-
trations in whole blood of approximately
0.04 µM for total PCBs and 0.005 µM for
OH-PCBs (3). Men in Latvia and Sweden
who reported high fish consumption had
plasma concentrations of total OH-PCBs
ranging from 170 to 2,200 ng/g lipid weight
(10–90th percentiles) and of total parent
PCB from 1,000 to 5,300 ng/g lipid weight
(4). This corresponded to OH-PCB concen-
trations of approximately 0.5–6 µM and
PCB concentrations of 2.5–15 µM in plasma
lipids. Much higher total PCB concentra-
tions, sometimes as high as 1 mM, are pre-
sent in top marine predators, especially in
fatty tissues (28,29). Fish that inhabit conta-
minated sites accumulate high concentrations
of PCB; a marine fish, the scup, collected
from a contaminated harbor had body bur-
dens of 272 µg/g dry weight (30). Intestinal
and hepatic concentrations of OH-PCBs
have not been reported in ﬁsh-eating people.
In animals, the liver is an important site of
distribution and the major site of cytochrome
P450-dependent biotransformation of PCB
(31–33). The OH-PCBs formed in the liver
may be secreted into blood or bile. One study
of the distribution of OH-PCBs between
blood and liver of rats treated with selected
PCB congeners showed that blood contained
1.7- to 3.5-fold higher concentrations than
liver (33). With IC50 values in the low
micromolar range for individual congeners,
as found in our studies, negative effects of
mixtures of OH-PCBs could be expected in
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Figure 5. Inhibition of 3-OH-BaP glucuronidation
by different OH-PCBs in channel catﬁsh intestinal
microsomes, presented as the percentage reduc-
tion of the control rate. Error bars represent SD.
Figure 6. IC50 values of the inhibition of 3-OH-BaP
glucuronidation by different OH-PCBs in channel
catfish intestinal microsomes. Error bars
represent SD.
Figure 7. Kinetics of the inhibition of 3-OH-BaP
glucuronidation by 4´-OH-CB 72. Abbreviations: S,
substrate concentration; v, reaction rate. Dashed
lines connect data points with equal amounts of










































































































































































Figure 4. Kinetics of the inhibition of 3-OH-BaP
sulfation by 4´-OH-CB 72. Abbreviations: S, sub-
strate concentration; v, reaction rate. Dashed
lines connect data points with equal amounts of
inhibitor. Error bars represent SD. Articles • OH-PCBs inhibit sulfation and glucuronidation
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organisms exposed to field situations as
described above.
In their studies, Kester et al. (11) also
found that the ortho-hydroxylated com-
pounds were the weakest inhibitors, whereas
the para-hydroxylated metabolites with two
adjacent chlorine substituents were the
strongest inhibitors. They concluded that
two or three chlorine substitutions in the
nonphenolic ring did not affect the inhibi-
tion potential, but that four or more chlo-
rine substituents negatively affected the
inhibitory potency. This is not conﬁrmed by
the results described here, as 4´-OH-CB 165
was a relatively potent inhibitor. 
Noncompetitive inhibition is described
as the kinetic type of inhibition for EST
(11). This would be in line with previously
reported cooperativity in EST, with the
inhibitor binding to an allosteric binding site
(34). Our data did not allow a distinction
between competitive, noncompetitive, or
uncompetitive inhibition because of nonlin-
earity in the double reciprocal and Eadie-
Hofstee plots. Nonlinearity can be caused by
a number of factors, among which are multi-
ple or partial inhibition, substrate, or prod-
uct inhibition, as well as by cooperativity
(35). Given the previous observations of
cooperativity in SULT, it will be interesting
to further investigate this phenomenon,
including the effects of inhibitors.
OH-PCBs have also been tested as
inhibitors of thyroid hormone sulfation
(9,10). IC50s ranged from 0.2 to 6.9 µM,
with the meta- and para-hydroxylated
metabolites as the most potent inhibitors,
whereas the ortho hydroxy-substituted PCBs
were very weak inhibitors of thyroid SULT
activity. This indicates a close resemblance
between the active sites of estrogen, thyroid,
and phenol-type SULT. There is overlap in
the substrate speciﬁcity of SULT (36). The
comparable inhibition activities of OH-PCBs
for the different types of SULT only empha-
sizes the similarities among the isoforms.
To date there have been no published
studies of the effect of OH-PCBs on UGTs
with endogenous or xenobiotic substrates.
Our results show that OH-PCBs are
inhibitors of SULT and UGT, but they
might also serve as substrates for these
enzymes. It has been suggested that sulfate
and glucuronosyl conjugates of OH-PCBs
would be excreted through bile and urine,
with bile as the preferred pathway (5).
However, actual data for this pathway are
not well documented. Evidence for sulfate or
glucuronosyl conjugates of OH-PCBs in bile
or urine was sparse [reviewed by Connor et
al. (27)]. OH-PCBs are only slightly less
lipophilic than the parent PCB, and if not
conjugated, are likely to be retained in lipid
fractions of tissues. Likewise, there are very
few studies describing in vitro experiments
on the conjugation of OH-PCBs (27).
The observed inhibitory effects of
OH-PCBs on the phase II conjugation of
BaP metabolites has implications concerning
the interactions of environmental chemicals.
PCBs and PAHs are often found together in
contaminated aquatic areas, and bottom-
dwelling ﬁsh that live in these areas are likely
to be exposed to this mixture. Metabolism of
PCBs will lead to the formation of a variety
of OH-PCBs, some of which may be bound
to thyroid hormone transporters in blood
plasma. These PCB metabolites resembling
thyroxine are also the most potent inhibitors
of phenol-type SULT and UGT. Structurally
related OH-PCBs were present in rat liver at
concentrations similar in order of magnitude
to those found in blood (33). The persistence
and systemic distribution of these OH-PCBs
may have important consequences for all reg-
ulatory processes that require sulfation or
glucuronidation and may also have a deleteri-
ous effect on the detoxiﬁcation of absorbed
environmental toxicants such as OH-PAHs
and other hydroxylated xenobiotics.
Comparison between the inhibition of
SULT and UGT shows that glucuronidation
is much more likely to be affected by
OH-PCB inhibition than sulfation. From a
kinetic standpoint, this is an interesting phe-
nomenon. For many substrates SULTs are
high-affinity–low-capacity enzymes that are
efficient at low substrate concentrations,
whereas UGTs are low-afﬁnity–high-capacity
enzymes that take over as a phase II conjugat-
ing enzyme when substrate concentrations
increase (37). This would mean, given the
differences in IC50s, that the effects of
OH-PCBs are likely to become apparent
when substrate concentrations increase, pos-
sibly leading to a synergistic effect in the
accumulation of harmful hydroxylated PAH
metabolites. 
In conclusion, this study reports for the
first time that OH-PCBs have a significant
inhibitory effect on phenol-type SULT and
UGT in channel catfish intestinal mucosa.
Some OH-PCBs inhibit UGT and SULT,
but particularly UGT, at environmentally
relevant, low micromolar concentrations.
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